This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients.
Frontiers in pharmacology, 14, 1088670
Citation
Liu, Xu; Song, Ling; Zhang, Yuanhui; Li, Haiyan; Cui, Cheng; Liu, Dongyang. (2023). PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients.. Frontiers in pharmacology, 14, 1088670. https://doi.org/10.3389/fphar.2023.1088670